why choose us

First received: May 11, 2023

Clinical Trial: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Liver Cirrhosis

Study Type: INTERVENTIONAL


Official Title: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Brief Summary: The goal of this clinical trial is to determine primarily whether a combinatorial therapy based on the administration of human albumin and enoxaparin is safe and effective in patients with decompensated cirrhosis discharged from the hospital.The main questions it aims to answer are:Is this combinatorial therapy safe and tolerable?Is this combinatorial therapy effective?does this combinatorial therapy cost more or less than standard medical therapy?Participants will attend to study visits in which several test will…

Read more